JPWO2020210485A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020210485A5 JPWO2020210485A5 JP2021559848A JP2021559848A JPWO2020210485A5 JP WO2020210485 A5 JPWO2020210485 A5 JP WO2020210485A5 JP 2021559848 A JP2021559848 A JP 2021559848A JP 2021559848 A JP2021559848 A JP 2021559848A JP WO2020210485 A5 JPWO2020210485 A5 JP WO2020210485A5
- Authority
- JP
- Japan
- Prior art keywords
- formula
- compound
- protecting group
- group
- nitrogen protecting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Description
特定の態様では、本開示は、式(I)
L3は、脱離基(
L3 is a leaving group (
用語「アミン」及び「アミノ」は、当該技術分野で認識されており、そして、非置換及び置換アミンの両方、及びそれらの塩のことを指しており、例えば、部分は、
式中、R9、R10、及びR10’は、それぞれ独立して、水素またはヒドロカルビル基を表す、または、R9及びR10は、それらが結合するN原子と共に互いに結合して、その環状構造に4~8個の原子を有する複素環を完成する。
The terms "amine" and "amino" are art-recognized and refer to both unsubstituted and substituted amines and salts thereof, e.g., the moiety
wherein R 9 , R 10 , and R 10 ′ each independently represent hydrogen or a hydrocarbyl group, or R 9 and R 10 are bonded together with the N atom to which they are bonded to form the cyclic Complete heterocycles with 4-8 atoms in the structure .
用語「カルバメート」は、当該技術分野で認識されており、そして、基
Claims (1)
L1は、脱離基である:
R1は、酸素保護基である;
R2は、共鳴受容性窒素保護基である;及び
R3は、C1-6アルキル、C2-6アルケニル、または、C2-6アルキニルである、前記プロセス。 Compounds of Formula (I)
L 1 is a leaving group:
R 1 is an oxygen protecting group;
The above process wherein R 2 is a resonance-accepting nitrogen protecting group; and R 3 is C 1-6 alkyl, C 2-6 alkenyl, or C 2-6 alkynyl.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962831962P | 2019-04-10 | 2019-04-10 | |
US62/831,962 | 2019-04-10 | ||
PCT/US2020/027459 WO2020210485A1 (en) | 2019-04-10 | 2020-04-09 | Process for preparing alpha-carboxamide pyrrolidine derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2022527213A JP2022527213A (en) | 2022-05-31 |
JPWO2020210485A5 true JPWO2020210485A5 (en) | 2023-05-17 |
Family
ID=72750576
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2021559848A Withdrawn JP2022527213A (en) | 2019-04-10 | 2020-04-09 | Process for preparing alpha-carboxamide pyrrolidine derivatives |
Country Status (12)
Country | Link |
---|---|
US (1) | US20220177426A1 (en) |
EP (1) | EP3953329A4 (en) |
JP (1) | JP2022527213A (en) |
KR (1) | KR20210150527A (en) |
CN (1) | CN114026066A (en) |
AU (1) | AU2020271856A1 (en) |
BR (1) | BR112021020345A2 (en) |
CA (1) | CA3136536A1 (en) |
EA (1) | EA202192762A1 (en) |
IL (1) | IL287078A (en) |
MX (1) | MX2021012420A (en) |
WO (1) | WO2020210485A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3691634A4 (en) | 2017-10-05 | 2021-03-31 | Biogen Inc. | Process for preparing alpha-carboxamide pyrolidine derivatives |
CN112812048B (en) * | 2021-01-20 | 2022-08-26 | 北京蓝博特科技有限公司 | Preparation method of sodium ion channel retarder CNV1014802 hydrochloride form |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3164597A (en) * | 1962-12-17 | 1965-01-05 | Geigy Chem Corp | 5-carboxylic acid-2-phenyl-pyrrolines, corresponding pyrrolidines and functional derivatives thereof |
TW200730494A (en) * | 2005-10-10 | 2007-08-16 | Glaxo Group Ltd | Novel compounds |
WO2008090114A1 (en) * | 2007-01-24 | 2008-07-31 | Glaxo Group Limited | Pharmaceutical compositions comprising 2-methoxy-5- (5-trifluoromethyl-tetrazol-i-yl-benzyl) - (2s-phenyl-piperidin-3s-yl-) |
ES2912881T3 (en) * | 2014-12-23 | 2022-05-30 | Convergence Pharmaceuticals | Procedure for preparing alpha-carboxamide pyrrolidine derivatives |
US9624169B2 (en) * | 2015-03-27 | 2017-04-18 | Scifluor Life Sciences, Inc. | Aryl- and heteroaryl-pyrrolidine-2-carboxamide compounds |
-
2020
- 2020-04-09 AU AU2020271856A patent/AU2020271856A1/en not_active Withdrawn
- 2020-04-09 EA EA202192762A patent/EA202192762A1/en unknown
- 2020-04-09 MX MX2021012420A patent/MX2021012420A/en unknown
- 2020-04-09 CA CA3136536A patent/CA3136536A1/en not_active Withdrawn
- 2020-04-09 CN CN202080042335.3A patent/CN114026066A/en not_active Withdrawn
- 2020-04-09 BR BR112021020345A patent/BR112021020345A2/en not_active Application Discontinuation
- 2020-04-09 KR KR1020217036558A patent/KR20210150527A/en unknown
- 2020-04-09 JP JP2021559848A patent/JP2022527213A/en not_active Withdrawn
- 2020-04-09 EP EP20788448.7A patent/EP3953329A4/en not_active Withdrawn
- 2020-04-09 US US17/602,585 patent/US20220177426A1/en active Pending
- 2020-04-09 WO PCT/US2020/027459 patent/WO2020210485A1/en unknown
-
2021
- 2021-10-07 IL IL287078A patent/IL287078A/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2022095872A5 (en) | ||
RU2005123485A (en) | DERIVATIVES OF PHOSPHONOOXYCHINAZOLINE AND THEIR PHARMACEUTICAL USE | |
JP2008509166A5 (en) | ||
KR880009041A (en) | Peptide derivatives, their preparation and use | |
JP2006507265A5 (en) | ||
KR890003679A (en) | Esters and Amides of Cyclic Carboxylic Acids and Cyclic Alcohols and Amines | |
JP2011527686A5 (en) | ||
US7553969B1 (en) | Substituted phenethylamine derivatives | |
JP2005511699A5 (en) | ||
KR920018053A (en) | Novel 8-substituted purines as selective adenosine receptors | |
CA2940455A1 (en) | Polymyxin derivatives and their use in combination therapy together with different antibiotics | |
CA2085715A1 (en) | Aminosulfonic acid derivatives and processes for their preparation | |
JPWO2020004649A5 (en) | ||
JPH08508720A (en) | Pyrrole-amidine compound and pharmaceutically acceptable salt thereof, process for producing the same and pharmaceutical composition containing the same | |
EP3344603A1 (en) | A production method of 1-(4-fluorobenzyl)-3-(4-isobutoxybenzyl)-1-(1-methylpiperidin- 4 yl)urea and its deuterated analogs not containing dimeric impurities | |
WO2023022231A1 (en) | Reversible covalent binding inhibitor for treating or preventing viral infection | |
JPWO2022038299A5 (en) | ||
PT1443046E (en) | Novel 4-(2furoyl)aminopiperidines, intermediates in synthesizing the same, process for producing the same and medicinal use of the same | |
JPWO2020210485A5 (en) | ||
JPH05500949A (en) | Gem-diphosphonic acid, its production method, and pharmaceutical compositions containing the same | |
NZ231750A (en) | Retroviral protease inhibitors and pharmaceutical compositions | |
JP2004529172A5 (en) | ||
Alexakis et al. | A practical and efficient synthesis of chiral N, N-disubstituted C2 symmetric diamines derived from (R, R)-1, 2-diaminocyclohexane | |
JPWO2019213445A5 (en) | ||
JP2015532915A (en) | Method for producing bortezomib |